All news and events

Research conducted with zebrafish can contribute to personalised medicine approaches, including the selection of the most individually suitable treatments for patients with cancer.

Ylönen currently works as the Director of the Open Science Centre of the University of Jyväskylä.

The method, called KMAP, enables intuitive visualisation of short DNA sequences and helps reveal how regulatory elements behave in different biological contexts.

A new study investigates the first experiences of Estonian and Finnish pharmacists with Cross-border ePrescription.

The doctoral study provides valuable insights into how deep learning can be used to address critical challenges in breast cancer screening, diagnosis, and genetic risk analysis.